Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A group has developed therapies that show promise for treating cancer and various other conditions.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

Non-melanoma skin cancer in darker-skinned people can be misdiagnosed, so doctors need to be more aware to diagnose it correctly and early.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Reducing SOX2 in colorectal cancer cells decreases tumor growth and self-renewal.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Stem cells play a key role in nonmelanoma skin cancers, with different origins and genetic changes linked to basal and squamous cell carcinomas.

Understanding breast cancer requires considering both medical advancements and social influences.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

Selenium supplements do not prevent cancer and may increase certain health risks.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Nanoparticle systems make cancer treatment less toxic.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Dietary phytoestrogens do not significantly affect testicular cancer risk.

Endocrine therapies for cancer significantly increase the risk of hair loss.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

Raman spectroscopy could effectively guide skin cancer surgery by identifying tumor margins.